These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2869507)

  • 21. Bioavailability of controlled-release metoclopramide. 1st communication: single dose study.
    Beckett AH; Behrendt WA; Hadzija BW
    Arzneimittelforschung; 1987 Feb; 37(2):221-4. PubMed ID: 3580026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and bioavailability of three different galenic nifedipine preparations.
    Pabst G; Lutz D; Molz KH; Dahmen W; Jaeger H
    Arzneimittelforschung; 1986 Feb; 36(2):256-60. PubMed ID: 3964332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Steady-state pharmacokinetic properties of a 24-hour prolonged-release formulation of ropinirole: results of two randomized studies in patients with Parkinson's disease.
    Tompson DJ; Vearer D
    Clin Ther; 2007 Dec; 29(12):2654-66. PubMed ID: 18201581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absorption of theophylline from conventional and sustained-release tablets.
    Fagerström PO; Mellstrand T; Svedmyr N
    Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):131-8. PubMed ID: 7228455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Steady-state kinetics of sustained-release phenylpropanolamine.
    Lönnerholm G; Grahnén A; Lindström B
    Int J Clin Pharmacol Ther Toxicol; 1984 Jan; 22(1):39-41. PubMed ID: 6698658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioavailability of quinidine in slow-release form. A comparison between two preparations containing quinidine bisulphate as the active constituent.
    Regårdh CG; Johnsson G; Lundborg P; Perrson BA
    Arzneimittelforschung; 1977; 27(9):1716-8. PubMed ID: 21671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single dose bioavailability of two different digoxin tablets.
    Jonkman JH; Gusdorf CF; van der Boon WJ; Grasmeijer G; Jedema JN
    Arzneimittelforschung; 1987 Jan; 37(1):62-5. PubMed ID: 3566859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and bioavailability of four modified-release ursodeoxycholic acid preparations for once-a-day administration.
    Simoni P; Sabatini L; Baraldini M; Mirasoli M; Roda A; Roda E
    Int J Clin Pharmacol Res; 2002; 22(2):37-45. PubMed ID: 12503774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic-dynamic study on different oral biperiden formulations in volunteers.
    Hollmann M; Müller-Peltzer H; Greger G; Brode E; Perucca E; Grimaldi R; Crema A
    Pharmacopsychiatry; 1987 Mar; 20(2):72-7. PubMed ID: 3588663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study.
    Wonnemann M; Schug B; Anschütz M; Brendel E; De Nucci G; Blume H
    Clin Ther; 2008 Jan; 30(1):48-58. PubMed ID: 18343242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the pharmacokinetics of miconazole after administration via a bioadhesive slow release tablet and an oral gel to healthy male and female subjects.
    Cardot JM; Chaumont C; Dubray C; Costantini D; Aiache JM
    Br J Clin Pharmacol; 2004 Oct; 58(4):345-51. PubMed ID: 15373926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioavailability of slow-release co-dergocrine mesylate (dihydroergotoxine) formulations.
    Woodcock BG; Habedank WD; Loh W; Herrmann W; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1987 Dec; 25(12):660-3. PubMed ID: 3436686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative bioavailability study of a conventional and two controlled release oral formulations of Tegretol (carbamazepine)--200 mg.
    Revankar SN; Bhatt AD; Desai ND; Bolar HV; Sane SP; Tipnis HP
    J Assoc Physicians India; 1999 Sep; 47(9):886-9. PubMed ID: 10778658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioavailability of Theodel, a new theophylline tablet, in humans.
    Rovei V; Strolin Benedetti M; Donath A; Grenot C; Chanoine F
    Int J Clin Pharmacol Ther Toxicol; 1983 Aug; 21(8):425-30. PubMed ID: 6629546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
    Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
    Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The use of Thomasin (etilefrin) in patients with basic neuroleptic, antidepressive and antiepileptic medication].
    Börner I; Gretzler H; Herbst A; Schläfke D
    Z Arztl Fortbild (Jena); 1982 Sep; 76(17):781-3. PubMed ID: 6128833
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacokinetics and bioavailability of pentaerithrityl tetranitrate and two of its metabolites.
    Weber W; Michaelis K; Luckow V; Kuntze U; Stalleicken D
    Arzneimittelforschung; 1995 Jul; 45(7):781-4. PubMed ID: 8573222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioavailability of controlled-release metoclopramide. 2nd communication: multiple dose study.
    Beckett AH; Behrendt WA; Hadzija BW
    Arzneimittelforschung; 1987 Feb; 37(2):224-8. PubMed ID: 3580027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral forms of the oxime HI-6: a study of pharmacokinetics and tolerance after administration to healthy volunteers.
    Jovanovic D; Maksimovic M; Joksovic D; Kovacevic V
    Vet Hum Toxicol; 1990 Oct; 32(5):419-21. PubMed ID: 2238436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.